Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 9.4B | 9.5B | 9.7B | 9.7B |
Cost of revenue | 7.7B | 7.8B | 8.1B | 8.0B |
Gross profit | 1.6B | 1.7B | 1.7B | 1.7B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 1.4B | 1.4B | 1.4B | 1.4B |
Other operating expenses | — | — | — | — |
Operating income | 229M | 304M | 288M | 352M |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 77M | 80M | 75M | 81M |
Other income expense | -4M | -137M | -12M | -2M |
Pretax income | 148M | 87M | 201M | 269M |
Tax provision | 33M | 21M | 53M | 71M |
Net income | 115M | 66M | 148M | 198M |
Basic EPS | 0.5 | 0.3 | 0.6 | 0.8 |
Diluted EPS | 0.5 | 0.3 | 0.6 | 0.8 |
Basic average shares | 230.5M | 232.3M | 241M | 246M |
Diluted average shares | 234.2M | 235.8M | 244M | 248M |
EBITDA | 342M | 414M | 399M | 457M |
Net income from continuing op. | 115M | 66M | 148M | 198M |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |